Cape Town-based marine biotechnology company MariHealth Solutions is stepping onto one of the global animal health industry’s most competitive stages, having been named the only African startup among 16 finalists selected for the 2026 Animal Health, Nutrition & Technology Innovation (AHNTI) Innovation Showcase in London.
The finalists drawn from four high-impact categories: Nutrition, Biopharma, Diagnostics and Technology, represent the next wave of science-led solutions targeting emissions reduction, antimicrobial resistance, veterinary therapeutics, precision diagnostics and digital health infrastructure.
For MariHealth Solutions, the selection signals international validation of an African deep-tech platform operating at the intersection of aquaculture, bioinformatics and climate resilience.
Sarah Carroll, PhD, co-founder and chief executive of MariHealth, announced the milestone this week. “This year has come in guns blazing,” she said. “I am super excited to share that MariHealth Solutions® has been selected as a finalist to present at the Animal Health & Nutrition Technology Innovation Summit in London in March.”
She added: “I look forward to connecting with animal health companies, regulatory consultants and companies working in the animal therapeutics space.”
Precision biology for a climate-stressed food system
MariHealth operates in the aquaculture healthcare sector, leveraging biotechnology to decode what it calls the industry’s “black box” the hidden metabolic and health signals that determine productivity and survival in farmed fish and shellfish.
Its business-to-business platform deploys a proteomics workflow coupled with deep data analytics to assess the metabolic status of aquatic livestock. The company translates complex protein datasets into practical decision-making tools for producers.
“Essentially, we remove the burden of dealing with and making sense of large protein datasets so our clients can focus on what really matters: optimizing and refining farming and nutrition through our robust decision support methodology,” the company has said.
The relevance is structural. Aquaculture now supplies more than half of global seafood consumption, yet disease outbreaks and feed inefficiencies continue to undermine output. In Africa where food security, export competitiveness and climate vulnerability intersect, biotechnology-driven diagnostics are emerging as commercial infrastructure rather than optional analytics.
The 16 finalists reshaping animal health
The 2026 AHNTI Innovation Showcase finalists reflect a decisive pivot toward science-intensive solutions.
Nutrition category:
- Agteria Biotech is developing a methane-reducing compound for cattle to lower agricultural emissions without compromising productivity.
- NanosVet provides dissolvable oral nanostrips delivering needle-free medicine, including an epinephrine equivalent for pets.
- PETDIETPLANS offers personalised diet plans and practical nutrition support for long-term pet wellness.
- PHAGE Lab develops bacteriophage-based alternatives to antibiotics, targeting antimicrobial resistance, a mounting global threat.
Biopharma category:
- bioaz advances animal health and welfare through high-impact biotechnology platforms.
- NanoVet Biotech is building camelid-derived nanobody programmes across dermatology, oncology and renal disease.
- Modulant Biosciences develops small-molecule therapeutics targeting multiprotein complexes implicated in infectious and chronic disease.
- Pasture Biosciences is engineering next-generation veterinary vaccines, including a cattle vaccine aimed at improving feed efficiency while reducing methane emissions.
Diagnostics category:
- PrediPet (alertix) has developed a blood test to detect and monitor tumour-related diseases in dogs.
- insituGen uses patented bioassay technology to measure steroid hormone bioactivity via sensitive, non-targeted screening.
- PICTOR delivers multiplex proteomics and ELISA-based testing for faster, lower-cost diagnostics across human and animal health.
- PRONOVA offers an at-home saliva biosensor platform that provides biomarker insights for dogs through a mobile app.
Technology category:
- Athian operates a carbon marketplace aggregating, verifying and monetising on-farm greenhouse gas reductions.
- MariHealth Solutions applies bioinformatics and deep data analytics to generate actionable biological insights.
- Photon Therapeutics is developing compliant, patient-focused ophthalmic solutions.
- Vet Vision AI uses AI-driven machine vision and real-time monitoring to generate welfare and behavioural intelligence.
African deep tech enters the global arena
The composition of the finalists underscores the convergence of climate mitigation, digital health and advanced biology in the future of animal agriculture. Methane reduction technologies, vaccine innovation, carbon marketplaces and molecular diagnostics are no longer fringe experiments; they are being built into mainstream investment theses.
For MariHealth, the London platform is strategic. It offers direct access to multinational animal health companies, pharmaceutical groups, regulatory advisers and institutional capital seeking science-backed, scalable models.
African startups have historically been associated with fintech and mobile infrastructure. That narrative is shifting. Biotechnology, climate-aligned agriculture and data-driven animal health are emerging as high-value export technologies.
In a world confronting food insecurity, antimicrobial resistance and tightening environmental regulation, the companies presenting in London are competing not for regional relevance but for global market share.
For a Cape Town marine biotech firm translating proteomic complexity into commercial insight, the message is clear. African-led deep tech is no longer peripheral to the global animal health industry.
